Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

F066 - Dealing with Difficult Patient Encounters

Saturday, February 17; 1:00 PM - 3:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Demonstrate effective and compassionate patient-specific communication.
  • Identify when a patient encounter becomes "difficult".
  • Develop a plan for management of difficult patient encounters.


Challenging patient encounters are stressful for both dermatologists and patients. Examples include undesirable outcomes, delivery of bad news, adjusting to diverse patient populations, managing patient expectations and treating psychocutaneous disease. In these instances, communication requires especially delicate care and it helps to have a game plan. How one deals with difficult encounters is not only important for appropriately managing dermatologic conditions and fostering trusting patient-physician relationships, but can be essential for ethical and medicolegal considerations. This session will use various sample cases to provide tools to best approach and manage these seemingly difficult situations.


  • Baldwin, Hilary E., MD: Allergan, Inc. – A(H); Bayer – SP(NC); Dermira – I(Grants/Research Funding); Galderma Laboratories, L.P. – SP(H); Novan – I(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – SP(H); Valeant Pharmaceuticals International – SP(H);
  • Coley, Marcelyn K., MD: Catalent Pharma Solutions – E(S);
  • Jakus, Jeannette Rachel, MD: Celgene – A(H); Galderma Research & Development, LLC – C(H); GLG Life Tech Corp – C(H);
  • Koo, John Y. M., MD: AbbVie – SP(H); Celgene Corporation – SP(H); Eli Lilly and Company – C(Fees); Janssen Pharmaceuticals, Inc – SP(H); Leo Pharma Inc. – SP(H); Novartis Pharmaceuticals Corp. – SP(H); Ortho Dermatologics – SP(H); Pfizer Inc. – C(Fees); Regeneron – SP(H); Sun Pharmaceutical Industries Ltd. – SP(H); UCB – SP(H);
  • Sturgeon, Ashley, MD: no financial relationships exist with commercial interests.
Saturday, February 17
1:00 PM
Dr. Coley and Dr. Jakus / Introduction
1:05 PM
Dr. Coley / The Patient and Communication
1:15 PM
Dr. Jakus / Dealing With Kids And Adolescents
1:30 PM
Dr. Sturgeon / Dealing with Expectations
1:45 PM
Dr. Koo / Dealing With Pyschocutaneous Disease
2:05 PM
Dr. Baldwin / Dealing with Medicolegal Consequences
2:25 PM
All faculty / Panel - Floor Discussion
Event Details
  • Date
    Saturday, February 17
  • Time
    1:00 PM - 3:00 PM
  • Location
    Room 5B
  • CME Credits
  • Type
  • Marcelyn K. Coley, MD, FAAD
  • Jeannette Rachel Jakus, MD, FAAD
  • Ashley Sturgeon, MD, FAAD - Handout 1, Handout 2
  • Hilary E. Baldwin, MD, FAAD
  • John Y. M. Koo, MD, FAAD